| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vir Biotechnology, Inc. (VIR) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. VIR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 13.73M | $135.78M | - | |
| Dir | 1.10M | $10.88M | - | |
| CEO | 714.6K | $7.07M | - | |
| CFO | 160.1K | $1.58M | - | |
| VP | 104.6K | $1.03M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 2, 2022 | Pang Phillip80 | Chief Medical Officer | Sale+OE | 5,000 | $34.52 | $172,619.50 | -5.1% | -35.1% | -9.4% | |
| Jan 25, 2022 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 1,375 | $32.46 | $44,632.50 | -1.3% | -26.9% | -1.7% | |
| Jan 19, 2022 | Pang Phillip80 | Chief Medical Officer | Sale+OE | 5,000 | $35.06 | $175,304.17 | -2.6% | -31.6% | -20.9% | |
| Jan 18, 2022 | Sato Vicki L73 | Director | Sell | 15,173 | $37.39 | $567,385.23 | -1.0% | -35.6% | -26.7% | |
| Jan 11, 2022 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 1,375 | $35.10 | $48,262.50 | -1.3% | -37.4% | -24.7% | |
| Jan 5, 2022 | Pang Phillip80 | Chief Medical Officer | Sale+OE | 5,000 | $37.19 | $185,956.00 | -2.6% | -33.8% | -26.0% | |
| Dec 28, 2021 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 1,375 | $39.95 | $54,931.25 | -1.3% | -46.2% | -37.0% | |
| Dec 20, 2021 | Sato Vicki L73 | Director | Sell | 15,174 | $54.53 | $827,484.62 | -0.2% | -50.5% | -50.1% | |
| Dec 20, 2021 | Svf Endurance (cayman) Ltd86 | 10% Owner | Sell | 400,022 | $52.73 | $21,093,160.06 | -1.8% | -50.5% | -50.1% | |
| Dec 15, 2021 | Pang Phillip80 | Chief Medical Officer | Sale+OE | 5,000 | $50.72 | $253,608.15 | -1.3% | -55.5% | -51.2% |